Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment Juul M.P.A.

Slides:

Advertisements

Similar presentations

Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment Juul M.P.A.

Advertisements

Clavi syphilitici–an unusual presentation of syphilis

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis Juan Escalas, PhD, MD, Nicole Knöpfel, MD, Ana Martin-Santiago,

Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata Yong Hyun Jang, MD,

A girl with a solitary red bulla

Facial adenocarcinoma treated with intra-arterial chemotherapy

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Psoriasis is associated with lipid abnormalities at the onset of skin disease Lotus Mallbris, MD, PhD, Fredrik Granath, PhD, Anders Hamsten, MD, PhD,

Psoriasis: Latitude does make a difference

Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: Report of three cases Xiaoqing.

Baldness reversed by chemotherapy

Efficacy of simvastatin in plaque psoriasis: A pilot study

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD

Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis Federica Ricceri, MD, Leonardo.

Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Pediatric teledermatology: Observations based on 429 consults

Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell (‘Berti’) lymphoma after administration of adalimumab

JAK inhibitors in dermatology: The promise of a new drug class

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD

Juul M. P. A. van den Reek, Wietske Kievit, Robert Gniadecki, Jelle J

The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis Alan Menter, MD, Jennifer C. Cather, MD, Diane.

Assessing adherence with phototherapy protocols

Classic pseudoxanthoma elasticum in a patient with sickle cell disease

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Smoking and risk of psoriasis: A nationwide cohort study

Pilot study of a skin cancer education curriculum for medical students

Applying for dermatology residency is difficult and expensive

Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection Alberto Conde-Taboada, MD, Javier Pedraz Muñoz, MD, Lucía.

Seasonal variation of acne and psoriasis: A 3-year study using the Physician Global Assessment severity scale Vanessa Lindsay Pascoe, MD, Alexandra Boer.

Chauncey C. Caldwell, MD, Sami K. Saikaly, MD, Robert P

Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis Eric Sorenson, AB, Ethan Levin, MD, John Koo, MD, Timothy.

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

Treatment of psoriasis vulgaris using low-dose naltrexone

Partik Singh, BA, Jonathan I. Silverberg, MD, MPH, PhD

Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks

Infectious rash after riding elephants

Lip edema Journal of the American Academy of Dermatology

Lip and oral mucosal lesions in 100 renal transplant recipients

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Granulocyte and monocyte adsorption apheresis for leg ulcers in a patient with rheumatoid arthritis Takuro Kanekura, MD, PhD, Yuji Mochitomi, MD, Shizuyo.

Pediatric psoriasis treated with apremilast

Pityriasis rubra pilaris with polyarthritis treated with adalimumab

Hugh Gloster, MD, Chesahna Kindred, MBA

Seasonal patterns in alopecia areata, totalis, and universalis

Appearance of lentigines in psoriasis patients treated with apremilast

Medicaid acceptance among pediatric dermatologists

Pruritus severity in patients with psoriasis is not correlated with psoriasis disease severity David Roblin, MD, FRCP, Ro Wickramasinghe, PhD, MBA, Gil.

Penile calciphylaxis Journal of the American Academy of Dermatology

Increased risks of autoimmune rheumatic diseases in patients with psoriasis: A nationwide population-based study Hyun Jeong Ju, MD, Ki-Jo Kim, MD, PhD,

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Derek Y. Hsu, BA, Kenneth Gordon, MD, Jonathan I

Jose Fernández-Vozmediano, PhD, Jose Armario-Hita, MD

Michelle A. Pipitone, MD, Brian Adams, MD, MPH, Anita Sheth, MD, T

Etanercept therapy in two patients with psoriasis and concomitant hepatitis C Clara De Simone, MD, Andrea Paradisi, MD, Rodolfo Capizzi, MD, Angelo Carbone,

Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation Suelen Montagner, MD, Francisco Aparecido.

A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit.

Eyebrow transplantation: Alternative body sites as a donor source

Gaps in pain management in dermatology: A needs assessment from Canada

Numerous hyperpigmented macules of the oral mucosa

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Presentation transcript:

Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment Juul M.P.A. van den Reek, MD, Philippe A.R.R. Pijls, MD, Marcia Tummers, PhD, Piet C.L.M. van Riel, MD, PhD, Wietske Kievit, PhD, Frank Hoentjen, MD, PhD, Elke M.G.J. de Jong, MD, PhD Journal of the American Academy of Dermatology Volume 74, Issue 1, Pages 177-179 (January 2016) DOI: 10.1016/j.jaad.2015.08.010 Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Overall adalimumab drug survival in patients with plaque psoriasis (PP) (n = 115), Crohn's disease (CD) (n = 168), and rheumatoid arthritis (RA) (n = 176). Journal of the American Academy of Dermatology 2016 74, 177-179DOI: (10.1016/j.jaad.2015.08.010) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

Fig 2 Hazard ratios corrected for variables that explained differences in adalimumab drug survival between plaque psoriasis (PP), Crohn's disease (CD) and rheumatoid arthritis (RA) (n = 459). Journal of the American Academy of Dermatology 2016 74, 177-179DOI: (10.1016/j.jaad.2015.08.010) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions